Enables zinc ion transmembrane transporter activity. Involved in intracellular zinc ion homeostasis and zinc ion import into zymogen granule. Predicted to be located in cytoplasmic vesicle; lysosomal membrane; and mitochondrial inner membrane. Predicted to be active in plasma membrane. Orthologous to human SLC30A2 (solute carrier family 30 member 2); INTERACTS WITH 6-propyl-2-thiouracil; acetamide; all-trans-retinol.
[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A2 mRNA
[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A2 mRNA
[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC30A2 mRNA
[Zinc deficiency co-treated with Vitamin A deficiency] results in increased expression of SLC30A2 mRNA and SLC30A2 protein affects the localization of and results in increased export of Zinc
[Dexamethasone results in increased expression of SLC30A2] which results in decreased abundance of Zinc and Zinc promotes the reaction [MTF1 protein results in increased expression of SLC30A2 mRNA]
[Dexamethasone results in increased expression of SLC30A2] which results in decreased abundance of Zinc and Zinc promotes the reaction [MTF1 protein results in increased expression of SLC30A2 mRNA]
[Zinc deficiency co-treated with Vitamin A deficiency] results in increased expression of SLC30A2 mRNA and SLC30A2 protein affects the localization of and results in increased export of Zinc